Pandorum Technologies, Nucelion Therapeutics Partner to Manufacture Exosome-Based Therapy for Ocular Diseases in APAC Markets

Pandorum Technologies and Nucelion Therapeutics Announce Strategic Collaboration to Manufacture Exosome-Based Tissue Regenerative Therapy for Ocular Diseases in APAC Markets

BANGALORE, India & HYDERABAD, India--(BUSINESS WIRE)--Jan 6, 2026-

Pandorum Technologies, Nucelion Therapeutics partner to manufacture exosome-based therapy for ocular diseases in APAC markets

Pandorum Technologies, a clinical-stage regenerative medicine company building a next-generation platform for programmable tissue regeneration, announced a strategic collaboration with Hyderabad based Nucelion Therapeutics, a specialised contract research, development and manufacturing organisation (CRDMO), to expand manufacturing capabilities for Pandorum’s exosome-based therapeutic platform across the Asia-Pacific (APAC) region. This strategic…